Evidence map›Paper›PMID 42513717›Full record

ReviewMaterials (Basel, Switzerland)2026

Antimicrobial Agents in Fibrous Materials: A Comprehensive Review of Natural, Inorganic, and Organic Systems.

Xueyan Que, Junqing Bai, Hai Yao, Pingping Fu, Yuanbo Xu, Xiaoyan Zhang, Yuqing Cui, Yingting Li, Jiangtao Yu, Ling Xu

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xueyan QueState Key Laboratory of Vaccines for Infectious Diseases, Xiangan Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, Xiamen 361102, China.
Junqing BaiYangling Hesheng Irradiation Technologies Co., Ltd., Xianyang 712000, China.
Hai YaoState Key Laboratory of Vaccines for Infectious Diseases, Xiangan Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, Xiamen 361102, China.
Pingping FuState Key Laboratory of Vaccines for Infectious Diseases, Xiangan Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, Xiamen 361102, China.
Yuanbo XuJinduicheng Molybdenum Industry Co. Ltd., Weinan 714101, China.
Xiaoyan ZhangState Key Laboratory of Vaccines for Infectious Diseases, Xiangan Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, Xiamen 361102, China.
Yuqing CuiYangling Hesheng Irradiation Technologies Co., Ltd., Xianyang 712000, China.
Yingting LiState Key Laboratory of Vaccines for Infectious Diseases, Xiangan Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, Xiamen 361102, China.
Jiangtao YuYangling Hesheng Irradiation Technologies Co., Ltd., Xianyang 712000, China.
Ling XuState Key Laboratory of Vaccines for Infectious Diseases, Xiangan Biomedicine Laboratory, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University, Xiamen 361102, China.

Funding

"Four Chains" Integration Project of Qinchuangyuan Industrial Innovation Agglomeration Area 2025CY-JJQ-76High-Level Innovation and Entrepreneurship Talent Project of Qinchuangyuan QCYRCXM-2023-173National Natural Science Foundation of China (NSFC) project 52573179Natural Science Foundation of Shenzhen Municipality JCYJ20220530143401003Qinchuangyuan Scientist and Engineer Project 2025QCY-KXJ-037Science and Technology Projects of Fujian Province No. 2021Y4007Scientific Research Foundation of State Key Laboratory of Vaccines for Infectious Diseases, Xiangan Biomedicine Laboratory 2023XAKJ0101017
6 · The paper itself

Abstract

The escalating threat of antimicrobial resistance has spurred extensive research into antimicrobial fibers. While numerous reviews have comprehensively cataloged the classification and mechanisms of natural, inorganic, and organic antimicrobial agents, a critical gap remains: few have systematically evaluated the engineering strategies that translate intrinsic biocidal activity into durable, real-world fiber performance. This review addresses this gap by shifting focus from encyclopedic enumeration to a problem-oriented critical assessment of performance optimization strategies. We examine recent advances in natural fibers (bamboo, hemp, chitosan, jute) and synthetic fibers modified with antimicrobial agents, with emphasis on three core challenges-poor wash durability of natural agents, aggregation and leaching of inorganic nanoparticles (e.g., Ag, ZnO, MOFs), and structural limitations of organic agents (e.g., QACs, QPSs, N-halamines, PHMB). Key optimization routes, including covalent grafting, microstructural control (e.g., triaxial microfluidic spinning), organic-inorganic hybridization, and rechargeable N-halamine systems, are critically assessed for their effectiveness in enhancing washing resistance, stability, and antimicrobial synergy. Based on this comparative synthesis, we identify future directions-smart-responsive systems, sustainable processing pathways, and standardized evaluation protocols-to guide the rational design of next-generation high-performance antimicrobial fibers.

Indexed as

antimicrobial agentsartificial fibersnatural fibers

Identifiers

PMID42513717
PMCPMC13412885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.